The earlier, the better: the effects of different administration timepoints of sorafenib in suppressing the carcinogenesis of VEGF in rats.

Cancer Chemother Pharmacol · 2018 · PMC5754402 · PMID 29196964

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Although no statistical significance existed between the sorafenib groups, the survival times showed a decreasing trend that corresponded with the administration time of sorafenib.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.